语言学 发表于 2025-3-25 07:05:10

Submitted on: 14 August 2009.
Revised on: 09 October 2009.
Accepted on: 25 October 2009.

___________________HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

SPER 发表于 2025-3-25 10:42:14

http://reply.papertrans.cn/2/116/11594/11594-22.png

一再困扰 发表于 2025-3-25 15:32:58

Submitted on: 26 April 2016.
Revised on: 17 May 2016.
Accepted on: 04 July 2016.

___________________HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Duodenitis 发表于 2025-3-25 17:16:03

Submitted on: 08 April 2011.
Revised on: 06 May 2011.
Accepted on: 23 May 2011.

___________________HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

被告 发表于 2025-3-25 21:07:50

http://reply.papertrans.cn/2/116/11594/11594-25.png

僵硬 发表于 2025-3-26 00:59:06

http://reply.papertrans.cn/2/116/11594/11594-26.png

Fester 发表于 2025-3-26 05:02:42

Submitted on: 16 July 2007.
Revised on: 02 September 2007.
Accepted on: 03 October 2007.

___________________HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

持续 发表于 2025-3-26 09:38:04

Submitted on: 08 June 2004.
Revised on: 24 September 2004.
Accepted on: 10 October 2004.

___________________HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

breadth 发表于 2025-3-26 15:59:01

Submitted on: 04 January 1999.
Revised on: 29 April 1999.
Accepted on: 18 June 1999.

___________________HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

beta-cells 发表于 2025-3-26 20:20:30

http://reply.papertrans.cn/2/116/11594/11594-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL 2024/2025影响因子:1.805 (HUM PSYCHOPHARM CLIN) (0885-6222). (PHARM